Jj. Bowden et al., DEXAMETHASONE AND OXYTETRACYCLINE REVERSE THE POTENTIATION OF NEUROGENIC INFLAMMATION IN AIRWAYS OF BATS WITH MYCOPLASMA-PULMONIS INFECTION, American journal of respiratory and critical care medicine, 150(5), 1994, pp. 1391-1401
Citations number
60
Categorie Soggetti
Emergency Medicine & Critical Care","Respiratory System
Mycoplasma pulmonis infection in rats causes a chronic inflammatory ai
rway disease. Along with extensive remodeling of the airway mucosa, ly
mphocytic infiltrates, angiogenesis, and mucosal thickening, there is
an abnormal sensitivity of the blood vessels to mediators that evoke '
'neurogenic inflammation.'' As a result, substance P, a peptide releas
ed from sensory nerves, produces an unusually large amount of plasma l
eakage. These changes can be prevented or reduced by prophylactic trea
tment with antibiotics, but it is unknown whether the extensive remode
ling of the airway mucosa and potentiation of neurogenic inflammation
can be reversed once they are established. We addressed this issue in
F344 rats that were infected with M. pulmonis at 8 wk of age. Six week
s later, the rats were treated daily with an antibiotic (oxytetracycli
ne, 20 mg/kg intramuscularly), to reduce the number of infecting organ
isms, or with an antiinflammatory steroid (dexamethasone, 0.5 mg/kg in
traperitoneally), to reduce the inflammatory and immunologic response
to the infection. Sham-treated infected rats received daily injections
of 0.9% NaCl. After 1, 2, or 4 wk of treatment the rats were anesthet
ized and then challenged with substance P (5 mu g/kg intravenously). T
he sham-treated rats had pathologic changes in their airways typical o
f severe M. pulmonis infection, and had as much as a threefold increas
e in substance P-induced plasma leakage. By comparison, after 4 wk of
treatment with oxytetracycline or dexamethasone the chronic inflammati
on was nearly resolved and the response to substance P was in the norm
al range. Unexpectedly dexamethasone, like oxytetracycline, reduced th
e number of infecting organisms. We conclude that the potentiation of
neurogenic inflammation and many of the other changes associated with
the chronic airway disease produced by M. pulmonis infection can be re
versed by antibiotics or antiinflammatory steroids.